Gene · 58191
Papers4,127
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 4,127
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interferon partly dictates a divergent transcriptional response in poxvirus-infected and bystander inflammatory monocytes. | Cell Rep | 2022 | 36417857 | PubTator, text mining | PubMed |
| The immunological mechanisms and therapeutic potential in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. | Cell Biosci | 2022 | 36414987 | PubTator, text mining | PubMed |
| Exploring the pathogenesis of age-related macular degeneration: A review of the interplay between retinal pigment epithelium dysfunction and the innate immune system. | Front Neurosci | 2022 | 36408381 | PubTator, text mining | PubMed |
| Immune niches orchestrated by intestinal mesenchymal stromal cells lining the crypt-villus. | Front Immunol | 2022 | 36405734 | PubTator, text mining | PubMed |
| Pan-cancer analysis identifies migrasome-related genes as a potential immunotherapeutic target: A bulk omics research and single cell sequencing validation. | Front Immunol | 2022 | 36405728 | PubTator, text mining | PubMed |
| Quantitative bone imaging biomarkers and joint space analysis of the articular Fossa in temporomandibular joint osteoarthritis using artificial intelligence models. | Front Dent Med | 2022 | 36404987 | PubTator, text mining | PubMed |
| Identification of CKS2 and RRM2 as potential markers of vitiligo using bioinformatics analysis. | Medicine (Baltimore) | 2022 | 36401415 | PubTator, text mining | PubMed |
| Regulatory Networks, Management Approaches, and Emerging Treatments of Nonalcoholic Fatty Liver Disease. | Can J Gastroenterol Hepatol | 2022 | 36397950 | PubTator, text mining | PubMed |
| Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma. | J Exp Clin Cancer Res | 2022 | 36397148 | PubTator, text mining | PubMed |
| New insights into iNKT cells and their roles in liver diseases. | Front Immunol | 2022 | 36389715 | PubTator, text mining | PubMed |
| Human T lymphocytes at tumor sites. | Semin Immunopathol | 2022 | 36385379 | PubTator, text mining | PubMed |
| Innate immune imprints in SARS-CoV-2 Omicron variant infection convalescents. | Signal Transduct Target Ther | 2022 | 36379915 | PubTator, text mining | PubMed |
| Induction of pyroptotic cell death as a potential tool for cancer treatment. | J Inflamm (Lond) | 2022 | 36376979 | PubTator, text mining | PubMed |
| Keeping T cell memories in mind. | Trends Immunol | 2022 | 36369103 | PubTator, text mining | PubMed |
| Therapeutic Potential of d-MAPPS™ for Ocular Inflammatory Diseases and Regeneration of Injured Corneal and Retinal Tissue. | Int J Mol Sci | 2022 | 36362313 | PubTator, text mining | PubMed |
| Platelets and Their Role in Hemostasis and Thrombosis-From Physiology to Pathophysiology and Therapeutic Implications. | Int J Mol Sci | 2022 | 36361561 | PubTator, text mining | PubMed |
| Secreted Factors and Extracellular Vesicles Account for the Immunomodulatory and Tissue Regenerative Properties of Bone-Marrow-Derived Mesenchymal Stromal Cells for Osteoarthritis. | Cells | 2022 | 36359897 | PubTator, text mining | PubMed |
| Regenerative Medicine-Based Treatment for Vitiligo: An Overview. | Biomedicines | 2022 | 36359263 | PubTator, text mining | PubMed |
| The Monocyte, a Maestro in the Tumor Microenvironment (TME) of Breast Cancer. | Cancers (Basel) | 2022 | 36358879 | PubTator, text mining | PubMed |
| Effects of Benzene: Hematological and Hypersensitivity Manifestations in Resident Living in Oil Refinery Areas. | Toxics | 2022 | 36355969 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58191/papers?page=46